A B S T R A C T The oligopeptide chemoattractant receptor on human polymorphonuclear leukocyte (PMN) membranes exists in two affinity states. Since guanine nucleotides regulate the binding affinity and transductional activity of several other types of receptors, we examined the effect of nucleotides on the binding of N-formyl-methionyl peptides to their receptors on human PMN membranes. The addition of guanylylimidodiphosphate (0.1 mM), a nonhydrolyzable derivative of guanosine triphosphate (GTP), to PMN membrane preparations reduced the fraction of high-affinity receptors detected in equilibrium binding studies from 21.3±0.13 to 11.8±0.05% (P < 0.03), without altering the binding affinities. Since the total number of receptors remained unchanged, the effect of guanylylimidodiphosphate was to convert a portion of the receptors from the high-affinity state to the low-affinity state. At the maximal concentration of guanine nucleotide tested, '50% of the high-affinity sites were converted to low-affinity sites. The findings obtained by equilibrium binding were supported by kinetic studies since the dissociation of the radiolabeled oligopeptide chemoattractant N-formyl-methionyl-leucyl-[3H]phenylalanine from PMN membranes was accelerated in the presence of guanine nucleotide. The effect of guanine nucleotides was reversed upon washing, indicating that affinity conversion is bidirectional. The guanine nucleotide effects were greatest with nonhydrolyzable derivatives of GTP followed by GTP then guanosine diphosphate. Neither guanosine monophosphate nor any adenine nucleotide tested had an Address reprint requests to Dr. R. Snyderman.
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Guanine nucleotides have been shown to be important regulators of the activities of several hormone receptors, such as glucagon (5), a-and B-adrenergic (6), muscarinic cholinergic (7), and dopaminergic receptors (8 Binding assays. All experiments were performed at 25°C and each determination was performed in duplicate. The mean of the duplicates were used to calculate all data. The standard error of the mean of the replicates did not extend beyond the symbols used to represent the data points on the accompanying figures. The equilibrium binding assay conditions were as previously described (2) . The membrane preparations were kept on ice until assayed, at which time the preparations were incubated for 15 min with buffer or p[NH]ppG in order that the temperature of the preparations be equilibrated at 25°C. The membranes were then incubated with the radioligand for 30 min at 25°C. Nonspecific binding was defined as the amount of radioligand bound in the presence of at least 1,000-fold excess of unlabeled ligand. The highest concentration of the radioligand used was 50 nM and thus 50 uM FMLP was the concentration used to establish nonspecific binding. Incubation was stopped by rapid filtration through Whatman GF/C filters (Whatman Laboratory Products, Inc., Clifton, NJ) followed by four 5-ml washes with ice-cold incubation buffer. The filters were then counted in a liquid scintillation counter (Beckman Instruments, Inc., Fullerton, CA).
'Abbreviations used in this paper: FMLP, N-formylmethionyl-leucyl-phenylalanine; GTP, guanosine-5'-triphosphate; GTP'yS, guanosine-5'-0-3-thiotriphosphate; HPLC Computer modeling. The data from saturation binding assays, that is, the amount of radioligand bound vs. amount of radioligand added, were subjected to nonlinear least squares curve fitting using a computer method developed by DeLean et al. (10, 11) . This method is based on the law of mass action and allows the analysis of the binding of a radioligand to multiple classes of binding sites. The data was fitted to one-and two-site models successively and a two-site model was accepted only when the fit of the data was significantly improved (P < 0.01). The computer analysis yields affinity constants and concentrations for each class of receptors. The dissociation constants reported are the geometric means±SE (10).
RESULTS
Effect of guanine nucleotide on equilibrium binding characteristics. Membranes were preincubated with or without the guanine nucleotide (lo M) for 15 min at 25°C and then assayed for radioligand binding under equilibrium conditions. Fig. 1 Fig. 5 shows that the inhibition of radioligand binding is dose dependent. The concentration at which p[NH]ppG produced a half-maximal effect was 106 M. Similar experiments were performed using GTP and the concentration producing half-maximal inhibition was 5 X 10-6 M. This decrease in the fraction of high-affinity receptors coupled with no decrease in the total number of receptors suggests that in the presence of guanine nucleotides the reduction of high-affinity receptors is due to the conversion of receptors from the high-affinity state to those in a low-affinity state. Guanine nucleotides also enhanced the rate of dissociation of FML[3H]P from PMN membranes. The effects of the nucleotides were reversible by washing, indicating interconvertibility of the receptor from low to high affinity as well.
Guanine nucleotide regulation of interconvertible receptor affinity states has been demonstrated in a number of instances where receptors are coupled to the enzyme adenylate cyclase (5) (6) (7) (8) . At the f,-adrenergic receptor, guanine nucleotides effect conversion of receptors from high to low affinity and have been shown to regulate the agonist-induced formation of a receptor-guanine nucleotide regulatory protein complex, which is involved in the signal transduction process (6) . Guanine nucleotides, at a sufficiently high concentration cause conversion of all the ,B-adrenergic receptors to a single low-affinity population of receptors. This was not observed for the chemoattractant receptors, where only half of the high-affinity sites could be converted to low-affinity. However, the muscarinic cholinergic receptor, which appears to be regulated by guanine nucleotides, has also been reported not to be completely converted to a homogeneous lowaffinity receptor population by high concentrations of p[NH]ppG (7). The possibility exists that for the muscarinic cholinergic and chemotactic receptors, even the high concentration of guanine nucleotides used was not sufficient for the conversion to be completed. Alternatively, a subpopulation of high-affinity receptors may exist, which are independent of guanine nucleotide control. This contention is supported by the finding that FMLP preincubation increases the fraction of guanine nucleotide-insensitive high-affinity binding sites in human PMN membranes (12) . It has also been shown that human PMN are not a homogeneous population of cells (13) and this heterogeneity could be reflected in heterogeneous regulation of chemoattractant receptors on the membranes of these cells.
Nonetheless, the widespread occurrence of guanine nucleotide modulation of agonist binding has suggested that this property reflects early activation steps that subsequently result in the observed biological responses. In the f3-adrenergic system, the formation of the receptor-guanine nucleotide regulatory protein complex facilitates the activation of the enzyme adenylate cyclase by the nucleotides, while the muscarinic cholinergic receptor has been demonstrated to inhibit the activation of adenylate cyclase (14, 15) .
Although chemoattractants have been shown to produce an accumulation of intracellular cAMP (16, 17) , attempts to demonstrate a direct activation or inhibition of adenylate cyclase by chemoattractants have been unsuccessful (18) .
Guanine nucleotide regulatory proteins are not solely involved with modulation of adenylate cyclase activity. Recently, light activation of rhodopsin has been shown to result in a guanine nucleotide-regulated activation of a cGMP phosphodiesterase (19) . Thus, guanine nucleotide regulation appears to be involved in linking a variety of receptors to the activation or inhibition of effector enzymes required for the function of these receptors. The data presented here suggest that guanine nucleotide regulatory protein may be required for certain aspects of stimulus-receptor coupling of the chemoattractant receptor. The effector units to which these receptors may be coupled by nucleotide regulatory proteins remain to be determined.
